Ray of hope: Pfizer/BioNTech’s Covid-19 vaccination approved in UKUncategorised
Posted by: The Probe 2nd December 2020
The UK has become the first question to approve one of the several Covid-19 vaccines in development. The Pfizer/BioNTech’s Covid-19 vaccine has been approved by UK regulator the MHRA, which has concluded that the vaccination is 95% effective in protecting against the Coronavirus, and that it is safe to be rolled out.
Health secretary Matt Hancock has stated that the first 800,000 doses will be available from next week, with the elderly, those in care homes and some NHS staff being given priority. Mr Hancock added that people should wait to be contacted by the NHS regarding vaccination.
The UK had already ordered 40 million doses of the Pfizer/BioNTech jab while it was in development, which will be enough to vaccinate up to 20 million people, as two doses are required three weeks apart, with the second injection serving as a booster to increase the vaccine’s effectiveness.
Several million doses are expected to be given during December, with the majority of the British public receiving the jab in the new year. The hope is that life can resume some semblance of normality by the summer of 2021.
The vaccine will be made available through a combination of hospitals, vaccination centres (set up in the same manner as the Nightingales project), and in the community via GPs and pharmacists. Whether NHS dentists will be called into action remains yet to be seen.
Either way, this is incredibly positive news for us all after what has been an extremely trying year. As preparations begin for what NHS chief executive Sir Simon Stevens describes as “the largest-scale vaccination campaign in our country’s history”, there is finally a light at the end of the tunnel.
No comments yet.
Sorry, the comment form is closed at this time.